- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT01053468
Facilitating Physical Activity Behavior and Health Outcomes in Breast Cancer Patients Receiving Chemotherapy (PROACTIVE)
Breast cancer and its treatments can take a toll on the physical and psychosocial well-being of cancer survivors. Few interventions can help breast cancer patients improve their physical strength, stamina, and overall well-being. Developing ways to facilitate PA behavior during chemotherapy for breast cancer are necessary. This trial explores ways that breast cancer patients receiving chemotherapy can learn about and engage in PA during chemotherapy. This trial will also give Southern Alberta breast cancer survivors an opportunity to participate in evidence-based programs designed to facilitate their health, breast cancer recovery, and disease-free survival.
The investigators primary hypothesis is that women receiving the PA intervention resource kit will report a more positive change in self-reported PA at the end of chemotherapy treatments when compared to the group receiving standard materials.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Primary Objective:
To compare the effects of an evidence-based intervention consisting of targeted breast-cancer specific PA print materials (i.e., Exercise for health), a step pedometer, a step-walking guidebook (i.e., Step into survivorship), and a physical activity and step journal (INT) to a comparison group receiving a generic, two-page public health PA resource (Standard Material: SM).
Type d'étude
Inscription (Anticipé)
Phase
- Phase 2
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jeff Vallance, PhD
- Numéro de téléphone: 403-488-7179
- E-mail: jeffv@athabascau.ca
Sauvegarde des contacts de l'étude
- Nom: Celeste Lavallee, BSc, RD
- E-mail: clavallee@athabascau.ca
Lieux d'étude
-
-
Alberta
-
Calgary, Alberta, Canada
- Recrutement
- Tom Baker Cancer Centre
-
Grande Prairie, Alberta, Canada
- Recrutement
- Grande Prairie Cancer Centre
-
Lethbridge, Alberta, Canada
- Recrutement
- Lethbridge Cancer Centre
-
Medicine Hat, Alberta, Canada
- Recrutement
- Medicine Hat Cancer Centre
-
Red Deer, Alberta, Canada
- Recrutement
- Central Alberta Cancer Centre
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- are diagnosed with stage I -IIIA breast cancer
- are scheduled to receive neoadjuvant or adjuvant chemotherapy
- did not receive transabdominal rectus abdominus muscle (TRAM) reconstructive surgery
- are >18 years of age
- receive approval from their treating oncologist to participate
- do not have uncontrolled hypertension, cardiac illness, or psychiatric conditions (i.e., indicated in patient medical charts).
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Soins de soutien
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Expérimental: PA Behavior Intervention
Physical Activity Resource Kit
|
The Intervention group (INT) will receive a Physical Activity Resource Kit which includes a step pedometer, a breast cancer-specific Physical Activity Guidebook (Exercise for health), a step pedometer resource (Step into survivorship), and a physical activity and step journal to record their daily step totals and daily physical activities. Participants will be instructed to wear their pedometer for the entire duration of the study (i.e., chemotherapy duration). |
Comparateur actif: Standard Materials
Receive physical activity handout from the Canadian Public Health Agency
|
Participants in this usual care group will receive a generic physical activity leaflet from the Canadian Public Health Agency
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Self-reported physical activity
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Cancer specific health related quality of life
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Psychosocial health outcomes
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Objective step counts (pedometer)
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Chemotherapy completion rate
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Determinants of physical activity
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Physical functioning
Délai: Baseline, post intervention, 6 months follow up
|
Baseline, post intervention, 6 months follow up
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Jeff Vallance, PhD, Athabasca University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- PROACTIVE
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Cancer du sein
-
AstraZenecaRecrutementAdv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian CancerEspagne, États-Unis, Belgique, Royaume-Uni, France, Hongrie, Canada, Corée, République de, Australie
Essais cliniques sur Physical Activity Resource Kit
-
Universiteit AntwerpenUniversity Hospital, Antwerp; Cliniques universitaires Saint-Luc- Université...RecrutementHémophilie A | Hémophilie BBelgique